Acitretin for the treatment of cutaneous T-cell lymphoma

Journal of the American Academy of Dermatology

Volumn 68, Issue 2, 2013, Pages 247-254

  Cheeley, Justin ^a   Sahn, Rachel E ^a   Delong, Laura K ^a,b,c   Parker, Sareeta R ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GRADY HEALTH SYSTEM   (United States)

^c ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

acitretin; adjuvant; cutaneous T cell lymphoma; mycosis fungoides; response; retinoid; therapy

Indexed keywords

BEXAROTENE; ETRETIN;

ADULT; AGED; ALOPECIA; ARTHRITIS; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER STAGING; CHEILITIS; CLINICAL ARTICLE; CUTANEOUS T CELL LYMPHOMA; DEPRESSION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSLIPIDEMIA; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; PRURITUS; SEZARY SYNDROME; SKIN ABRASION; TREATMENT DURATION; TREATMENT RESPONSE; XEROSIS;

ACITRETIN; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; RETROSPECTIVE STUDIES; SEZARY SYNDROME; SKIN NEOPLASMS; TETRAHYDRONAPHTHALENES; TREATMENT OUTCOME;

EID: 84872335250     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2012.07.013     Document Type: Article

References (18)

1. V.D. Criscione, and M.A. Weinstock Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002 Arch Dermatol 143 2007 854 859
2. F. Sampogna, M. Frontani, G. Baliva, G.A. Lombardo, G. Alvetreti, and C. Di Pietro Quality of life and psychological distress in patients with cutaneous lymphoma Br J Dermatol 160 2009 815 822
3. F.J. Kaye, P.A. Bunn Jr., S.M. Steinberg, J.L. Stocker, D.C. Ihde, and A.B. Fischmann A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides N Engl J Med 321 1989 1784 1790
4. Y.H. Kim, K. Bishop, A. Varghese, and R.T. Hoppe Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome Arch Dermatol 131 1995 1003 1008
5. L.K. Dunn, L.R. Gaar, B.A. Yentzer, J.L. O'Neill, and S.R. Feldman Acitretin in dermatology: a review J Drugs Dermatol 10 2011 772 782
6. R. Stadler, H.-G. Otte, T. Luger, B.M. Henz, P. Kuhl, and T. Zwingers Prospective randomized multicenter clinical trial on the use of interferon α-2a plus acitretin versus interferon α-2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II Blood 92 1998 3578 3581
7. N. Pimpinelli, E.A. Olsen, M. Santucci, E. Vonderheid, A.C. Haeffner, and S. Stevens Defining early mycosis fungoides J Am Acad Dermatol 53 2005 1053 1063
8. E. Olsen, E. Vonderheid, N. Pimpinelli, R. Willemze, Y. Kim, and R. Knobler Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC) Blood 110 2007 1713 1722
9. E. Hoting, and K. Meissner Arotinoid-ethylester: effectiveness in refractory cutaneous T-cell lymphoma Cancer 62 1988 1044 1048
10. W. Kempf, N. Kettelhack, M. Duvic, and G. Burg Topical and systemic retinoid therapy for cutaneous T-cell lymphoma Hematol Oncol Clin North Am 17 2003 1405 1419
11. M. Duvic, A.G. Martin, Y. Kim, E. Olsen, G.S. Wood, and C.A. Crowley Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma Arch Dermatol 137 2001 581 593
12. R. Talpur, S. Ward, N. Apisarnthanarax, J. Breuer-Mcham, and M. Duvic Optimizing bexarotene therapy for cutaneous T-cell lymphoma J Am Acad Dermatol 47 2002 672 684
13. Drugstore.com. Targretin. Available from: URL: https://www.drugstore.com/ targretin/75mg-capsules/qxn62856060210. Accessed January 28, 2012.
14. Drugstore.com. Soriatane. Available from: URL: https://www.drugstore.com/ soriatane/25mg-capsules/qxn00145009125. Accessed January 28, 2012.
15. J.N. Bavinck, L.M. Tieben, F.J. Van der Woude, A.M. Tegzess, J. Hermans, and J. ter Schegget Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study J Clin Oncol 13 1995 1933 1938
16. K.R. Suchin, A.J. Cucchiara, S.L. Gottleib, J.T. Wolfe, B.J. DeNardo, and W.H. Macey Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institution Arch Dermatol 138 2002 1054 1060
17. K. Thomsen, H. Hammar, L. Molin, and G. Volden Retinoids plus PUVA (RePUVA) and PUVA in mycosis fungoides, plaque stage: a report from the Scandinavian mycosis fungoides group Acta Derm Venereol 69 1989 536 538
18. H.M. Prince, S. Whittaker, and R.T. Hoppe How I treat mycosis fungoides and Sézary syndrome Blood 114 2009 4337 4353